BiotechTube
Home/BaroPace/Michael Burnam, MD
MB

Michael Burnam, MD

Founder & CEO

BaroPace

Therapeutic Areas

Cardiovascular

BaroPace Pipeline

DrugIndicationPhase
PressurePace™ BRTHeart Failure with Preserved Ejection Fraction (HFpEF) caused by hypertensionPivotal Trial Preparation